NCAPG2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.621000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.847800E-01
Normal-vs-Stage2
5.197400E-01
Normal-vs-Stage3
8.777800E-01
Normal-vs-Stage4
7.817200E-01
Stage1-vs-Stage2
5.468800E-01
Stage1-vs-Stage3
6.726000E-01
Stage1-vs-Stage4
9.486800E-01
Stage2-vs-Stage3
3.891400E-01
Stage2-vs-Stage4
6.691200E-01
Stage3-vs-Stage4
6.880400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.527400E-01
Normal-vs-AfricanAmerican
5.285200E-01
Normal-vs-Asian
7.729200E-01
Caucasian-vs-AfricanAmerican
6.179600E-01
Caucasian-vs-Asian
4.849400E-01
AfricanAmerican-vs-Asian
4.701400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.890800E-01
Normal-vs-Female
5.217400E-01
Male-vs-Female
1.800980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.843200E-01
Normal-vs-Age(41-60Yrs)
4.710800E-01
Normal-vs-Age(61-80Yrs)
6.271000E-01
Normal-vs-Age(81-100Yrs)
4.321200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.129200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.258400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.782800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.253990E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.162200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.592000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.620000E-01
Normal-vs-Daily Drinker
6.344800E-01
Normal-vs-Weekly Drinker
5.483400E-01
Normal-vs-Occasional Drinker
3.183000E-01
Normal-vs-Social Drinker
3.047200E-01
Non Drinker-vs-Daily Drinker
9.778000E-01
Non Drinker-vs-Weekly Drinker
4.671200E-01
Non Drinker-vs-Occasional Drinker
9.166600E-01
Non Drinker-vs-Social Drinker
4.445800E-01
Daily Drinker-vs-Weekly Drinker
4.736600E-01
Daily Drinker-vs-Occasional Drinker
9.095000E-01
Daily Drinker-vs-Social Drinker
5.000800E-01
Weekly Drinker-vs-Occasional Drinker
4.831400E-01
Weekly Drinker-vs-Social Drinker
7.295800E-01
Occasional Drinker-vs-Social Drinker
4.262000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.875000E-01
Normal-vs-Grade 2
6.246800E-01
Normal-vs-Grade 3
6.411600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.103500E-03
Grade 1-vs-Grade 3
5.448600E-04
Grade 1-vs-Grade 4
5.875000E-01
Grade 2-vs-Grade 3
2.559800E-01
Grade 2-vs-Grade 4
6.246800E-01
Grade 3-vs-Grade 4
6.411600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.968600E-01
Normal-vs-NonDiabetic
5.465200E-01
Diabetic-vs-NonDiabetic
2.443400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.395000E-01
Normal-vs-NoPancreatitis
6.070800E-01
Pancreatitis-vs-NoPancreatitis
1.478420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.854200E-01
Normal-vs-N1
5.535000E-01
N0-vs-N1
6.991800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.526600E-01
Normal-vs-TP53-NonMutant
6.280800E-01
TP53-Mutant-vs-TP53-NonMutant
4.802600E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
